Ahuva Averin

6PUBLICATIONS
17CO-AUTHORS
Pacific Peoples social determinants of healthPanel data analysisPacific Peoples health policyAdolescent healthPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 07, 2026
Residual Disparities in US Adults Hospitalized due to All-Cause Pneumonia Following Implementation of Childhood 13-Valent Pneumococcal Conjugate Vaccine in National Immunization Program.

|Jan 21, 2026
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.

Diana Mendes, Ahuva Averin, Mark Atwood

|Jun 04, 2025
Cost-effectiveness of 13-valent pneumococcal polysaccharide conjugate vaccine in Indian adults aged ≥50 years.

Namrata Kulkarni, Ahuva Averin, Santosh Taur

|May 03, 2024
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults.

Lucila Rey-Ares, Ahuva Averin, Mercedes Mac Mullen

|Oct 13, 2022
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease.

Diana Mendes, Ahuva Averin, Mark Atwood

|Aug 05, 2022
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England.

Tendai Mugwagwa, Ahuva Averin, Mark Atwood

Pageof 1

Frequent Collaborators

3 joint publications

Tendai Mugwagwa

3 joint publications

Reiko Sato

3 joint publications

Andrew Vyse

3 joint publications

James Campling